This conference will identify, evaluate, and discuss the relevance and effectiveness of regulatory instruments for improving risk governance, both as they result from responding to and learning from crises, and as deliberate innovations in how regulatory power is exercised and shared. The speakers and panelists hail from many international institutions, disciplines, and organizations around the world. Case studies to be highlighted during the conference include the regulation of oil spills, nuclear accidents, financial crashes, pharmaceuticals, and chemicals; the use of behavioral insights and non-government networks in regulation; and more.
Venue: OECD Conference Centre, Paris, France
Schedule: The first day addresses how crisis events shape regulatory change and how regulatory institutions can learn from crises. This is the theme of a research project we are leading at Duke University on “Recalibrating Risk: Crises, Perceptions and Regulatory Change” (book forthcoming in 2015). The second day addresses how regulatory systems can be designed to learn and improve over time, both exhibiting adaptive policy innovation and stimulating technological innovation. Full schedule available for download (pdf).
More information and registration at the IRGC website.
The third and final workshop of the DNA Applications in Human Rights and Human Trafficking initiative will be held Friday, October 10. This workshop will develop feasability projects to explore the role of DNA in human trafficking victim identification and explore the ethical, privacy, political, and social implications of DNA collection of victims and family members.
For more information please email Sara Katsanis at firstname.lastname@example.org.
This initiative represents a partnership of the Duke Human Rights Center at KIE, the Franklin Humanities Institute, and Duke Science & Society, with funding from the Josiah Charles Trent Memorial Foundation.
Friday, October 10, 9am-1pm
Garage C105 Bay 4
Bioethicist Jennifer Miller, PhD, inaugural George C. Lamb, Jr. Regulatory Fellow, will give a talk entitled “Ethics and Trustworthiness in the Pharmaceutical Industry: Could Rating Help?” Dr. Miller’s talk will debut preliminary results for the rating system she created and is piloting to address ethics and global health concerns about the pharmaceutical industry. The pilot index ranks the 20 largest drug companies on their transparency in disseminating clinical trial results for newly approved drugs — addressing the concern that there is missing and misleading information about new medicines and vaccines that can compromise medical evidence, patient care and public health. The rating system works on the premises that sunlight can be a good disinfectant and that naming good practices and shaming bad ones can incentivize trustworthy reform within the industry where needed.
Dr. Miller is a lab fellow in the Edmond J. Safra Center for Ethics at Harvard University and has taught in Columbia University’s Bioethics and Cross Cultural Education Program and in Fordham University’s Schools of Business. She holds a PhD in Bioethics from Regina Apostolorum and a BS in physics from Fordham University.
Jennifer Miller will be speaking on October 6th as part of the Monday Seminar Series from 12:00-1:15 p.m. in 101 West Duke Building. For lunch, please email Bashar Alobaidi for RSVP information: email@example.com.